Evaluation of microvessel density with CD31 and CD105 in patients with psoriasis under methotrexate and acitretin therapy
Open Access
- 1 January 2020
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 37 (3) , 422-427
Abstract
Introduction Methotrexate and acitretin are known to be effective in the treatment of psoriasis, but the mechanisms of the effects of these drugs are not fully known. Aim To investigate the effect of methotrexate and acitretin on microvessel density (MVD) in psoriasis. Material and methods...Keywords
This publication has 16 references indexed in Scilit:
- Clinical and Capillaroscopic Modifications of the Psoriatic Plaque during Therapy: Observations with Oral AcitretinDermatology Research and Practice, 2013
- Antiangiogenic Effect of Methotrexate and PUVA on PsoriasisCell Biochemistry and Biophysics, 2013
- Effects of Methotrexate on Vascular Endothelial Growth Factor, Angiopoietin 1, and Angiopoietin 2 in Nasal PolypsAmerican Journal of Rhinology & Allergy, 2011
- Vascular endothelial growth factor in psoriasis: an indicator of disease severity and controlJournal of the European Academy of Dermatology and Venereology, 2009
- Angiogenesis drives psoriasis pathogenesisInternational Journal of Experimental Pathology, 2009
- Pathogenesis and clinical features of psoriasisThe Lancet, 2007
- The treatment of psoriasis vulgaris: 1% topical methotrexate gelInternational Journal of Dermatology, 2006
- Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancerLaboratory Investigation, 2004
- Expression of endoglin in the transition between psoriatic uninvolved and involved skinActa Dermato-Venereologica, 1998
- Quantification of microvascular changes in the skin in patients with psoriasisBritish Journal of Dermatology, 1992